TransMedics (TMDX) Accumulated Depreciation & Amortization (2018 - 2026)

TransMedics has reported Accumulated Depreciation & Amortization for 9 years, with the latest figure at $73.8 million in Q1 2026.

• For the quarter ending Q1 2026, Accumulated Depreciation & Amortization rose 57.43% year-over-year to $73.8 million; the trailing twelve-month figure through Mar 2026 stood at $73.8 million (up 57.43% YoY), and the FY2025 full-year result was $66.1 million, up 62.27% from the prior year.
• Accumulated Depreciation & Amortization for Q1 2026 stood at $73.8 million, up from $66.1 million in the prior quarter.
• The five-year high for Accumulated Depreciation & Amortization was $73.8 million in Q1 2026, with the low at $13.1 million in Q4 2022.
• Average Accumulated Depreciation & Amortization over 5 years is $40.4 million, with a median of $38.0 million recorded in 2024.
• Year-over-year, Accumulated Depreciation & Amortization jumped 34.86% in 2022 and jumped 99.59% in 2024.
• Tracing TMDX's Accumulated Depreciation & Amortization over 5 years: stood at $13.1 million in 2022, then soared by 62.18% to $21.3 million in 2023, then jumped by 91.21% to $40.7 million in 2024, then surged by 62.27% to $66.1 million in 2025, then climbed by 11.74% to $73.8 million in 2026.
• The last three Accumulated Depreciation & Amortization figures came in at $73.8 million (Q1 2026), $66.1 million (Q4 2025), and $60.6 million (Q3 2025), per Business Quant data.

Peer Comparison